Dark Forest Capital Management LP Ligand Pharmaceuticals Inc Transaction History

Dark Forest Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$68.53 - $87.91 $110,675 - $141,974	-1,615 Reduced 24.26%	5,043 $424,000
Q1 2024 May 15, 2024	BUY	$68.64 - $89.2 $457,005 - $593,893	6,658 New	6,658 $486,000
Q1 2023 May 12, 2023	BUY	$65.67 - $77.08 $127,990 - $150,228	1,949 New	1,949 $143,000
Q4 2021 Feb 11, 2022	SELL	$127.69 - $165.85 $2,298 - $2,985	-18 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$102.33 - $144.73 $38,066 - $53,839	-372 Reduced 95.38%	18 $3,000
Q2 2021 Aug 16, 2021	BUY	$113.03 - $155.64 $44,081 - $60,699	390 New	390 $51,000

255

18.1M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.87B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.